𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo

✍ Scribed by Jun Yu; Liang Qiao; Lars Zimmermann; Matthias P. A. Ebert; Hongxia Zhang; Wendy Lin; Christoph Röcken; Peter Malfertheiner; Geoffrey C. Farrell

Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
513 KB
Volume
43
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis

Peroxisome proliferator-activated receptor gamma (PPARgamma) has been implicated in the differentiation and growth inhibition of cancer cells. We examined the effects of PPARgamma activation by troglitazone on hepatocellular carcinoma (HCC) cell growth, proliferation, and apoptosis in vitro and in vivo. We also studied relationships between PPARgamma activation and cyclooxygenase-2 (COX-2) expression. Human HCC cell lines Huh7 and Hep3B were cultured in the presence or absence of troglitazone. Cell growth was determined via WST-1 assay, proliferation by cell cycle analysis and proliferating cell nuclear antigen (PCNA) Western blotting, and apoptosis by flow cytometry and TUNEL. Tumor growth after subcutaneous implantation of Huh7 cells in nude mice was monitored, and the effects of treatment with troglitazone were determined. In resected HCCs, PPARgamma expression was less compared with the histologically normal surrounding liver. In cultures of Hep3B and Huh7 cells, basal expression of PPARgamma was relatively low, but troglitazone caused dose-dependent induction of PPARgamma expression. Cell cycle analysis revealed a decreased proportion of cells in S phase, with arrest at G0/G1. Concomitant downregulation of PCNA and an increase in TUNEL staining, cells were consistent with decreased proliferation and induction of apoptosis by troglitazaone. Troglitazone-mediated PPARgamma activation also suppressed COX-2 expression and induced p27 in HCC cells. Administration of troglitazone to Huh7 tumor-bearing mice significantly reduced tumor growth and caused tumor regression. In conclusion, collectively, these results indicate that PPARgamma could be a regulator of cell survival and growth in HCC. PPARgamma therefore represents a putative molecular target for chemopreventive therapy or inhibition of liver cancer growth.

📜 SIMILAR VOLUMES

Soluble glypican 3 inhibits the growth o
Soluble glypican 3 inhibits the growth of hepatocellular carcinoma in vitro and in vivo
✍ Sandra I. Zittermann; Mariana I. Capurro; Wen Shi; Jorge Filmus 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 695 KB

## Abstract The heterogeneity of the molecular pathology of HCC poses a formidable obstacle to the development of non‐cytotoxic therapies. Several pro‐tumorigenic signaling pathways can be aberrantly activated in HCC, including those triggered by Wnts. Glypican‐3 (GPC3), a membrane‐bound heparan su

Suppression of growth of hepatocellular
Suppression of growth of hepatocellular carcinoma by sodium butyrate in vitro and in vivo
✍ Hidenao Yamamoto; Jiro Fujimoto; Eizo Okamoto; Jun-ichi Furuyama; Taiki Tamaoki; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 146 KB 👁 1 views

Treatment of HuH-7 human hepatocellular carcinoma (HCC) cells with 1-10 mM sodium butyrate (SB) resulted in growth inhibition in a dose-dependent manner. At 3 mM and higher concentrations, SB caused nuclear fragmentation and DNA ladder formation characteristic of apoptosis. In the treated cells, the

MAZ51, an indolinone that inhibits endot
MAZ51, an indolinone that inhibits endothelial cell and tumor cell growth in vitro, suppresses tumor growth in vivo
✍ Vladimir Kirkin; Wilko Thiele; Petra Baumann; Ralph Mazitschek; Katrin Rohde; Gu 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 400 KB 👁 1 views

## Abstract We have recently described MAZ51, an indolinone that blocks the ligand‐induced autophosphorylation of VEGFR‐3, a receptor tyrosine kinase that plays a central role in the regulation of lymphangiogenesis. Here we show that MAZ51 is able to block the proliferation of VEGFR‐3‐expressing hu

Antisense treatment against Ki-67 mRNA i
Antisense treatment against Ki-67 mRNA inhibits proliferation and tumor growth in vitro and in vivo
✍ Ingo Kausch; Anja Lingnau; Elmar Endl; Kirsten Sellmann; Irina Deinert; Timothy 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 317 KB 👁 1 views

## Abstract The Ki‐67 protein is tightly regulated and depends on the proliferative status of a cell. It is present in the nuclei of proliferating cells but absent in resting cells. Since transformation of malignant cells is frequently associated with high cell proliferation and since proliferation

Recombinant soluble glypican 3 protein i
Recombinant soluble glypican 3 protein inhibits the growth of hepatocellular carcinoma in vitro
✍ Mingqian Feng; Heungnam Kim; Yen Phung; Mitchell Ho 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 398 KB

other bacterial components is a distinct possibility. These observations were confirmed in a very similar study in Finland, 10 and a recent meta-analysis, 11 where the summary risk of lung cancer was 0.62 (0.52-0.75) for agricultural workers. The relative risk of lung cancer was below 1.0 for most s